# Hancock Jaffe Laboratories, Inc. (HJLI)

Source: https://www.quantisnow.com/company/HJLI
Generated: 2026-11-16T20:10:49.402Z

- Ticker: HJLI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2018
- Website: hancockjaffe.com

## About

Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.

## Latest HJLI news and filings

- 2021-10-01 21:29 UTC [SEC Form 8-K] [Hancock Jaffe Laboratories, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hancock-jaffe-laboratories-inc-filed-sec-form-8-k-amendments-to-1833470)
- 2021-10-01 11:02 UTC [enVVeno Medical Corporation Successfully Completes Rebranding](https://www.quantisnow.com/insight/envveno-medical-corporation-successfully-completes-rebranding-1829922)
- 2021-09-24 13:00 UTC [Conference Announcement] [Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann](https://www.quantisnow.com/insight/hancock-jaffe-to-participate-in-the-duologue-series-virtual-webinar-1807126)
- 2021-09-22 12:15 UTC [SEC Form 8-K] [Hancock Jaffe Laboratories, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/hancock-jaffe-laboratories-inc-filed-sec-form-8-k-other-events-1797361)
- 2021-09-21 20:00 UTC [Earnings Date] [Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs](https://www.quantisnow.com/insight/hancock-jaffe-announces-corporate-rebranding-to-reflect-prioritization-of-its-1794908)
- 2021-09-17 21:08 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-hancock-jaffe-laboratories-inc-1785481)
- 2021-09-16 01:50 UTC [SEC Form 4] [SEC Form 4: Gray Robert converted options into 1,042 units of Common Stock, increasing direct ownership by 19% to 6,614 units](https://www.quantisnow.com/insight/sec-form-4-gray-robert-converted-options-into-1042-units-1777722)
- 2021-09-16 01:50 UTC [SEC Form 4] [SEC Form 4: Jenusaitis Matthew converted options into 1,042 units of Common Stock, increasing direct ownership by 22% to 5,884 units](https://www.quantisnow.com/insight/sec-form-4-jenusaitis-matthew-converted-options-into-1042-units-1777721)
- 2021-09-15 12:05 UTC [Earnings Date] [Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021](https://www.quantisnow.com/insight/hancock-jaffe-to-host-corporate-update-conference-call-and-webcast-1773776)
- 2021-09-08 20:49 UTC [SEC Form 8-K] [SEC Form 8-K filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-hancock-jaffe-laboratories-inc-1752257)
- 2021-09-08 20:43 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-hancock-jaffe-laboratories-inc-1752205)
- 2021-09-07 12:05 UTC [Public Offering] [Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules](https://www.quantisnow.com/insight/hancock-jaffe-laboratories-announces-20-million-registered-direct-offering-priced-1744246)
- 2021-08-27 19:19 UTC [SEC Form 4] [SEC Form 4: Jenusaitis Matthew bought $10,010 worth of Common Stock (1,300 units at $7.70), increasing direct ownership by 37% to 4,842 units](https://www.quantisnow.com/insight/sec-form-4-jenusaitis-matthew-bought-10010-worth-of-common-1716378)
- 2021-08-19 12:00 UTC [Conference Announcement] [Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society for Vascular Surgery Annual Meeting](https://www.quantisnow.com/insight/hancock-jaffe-presents-new-positive-two-year-venovalve-data-at-the-1687630)
- 2021-08-12 21:26 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-hancock-jaffe-laboratories-inc-1665094)
- 2021-08-12 21:28 UTC [SEC Form 8-K] [SEC Form 8-K filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-hancock-jaffe-laboratories-inc-1665081)
- 2021-08-06 20:31 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-hancock-jaffe-laboratories-inc-1639497)
- 2021-08-03 12:05 UTC [FDA Grants Breakthrough Device Designation Status for Hancock Jaffe's VenoValve](https://www.quantisnow.com/insight/fda-grants-breakthrough-device-designation-status-for-hancock-jaffes-venovalve-1594223)
- 2021-07-08 13:05 UTC [Conference Announcement] [Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference](https://www.quantisnow.com/insight/hancock-jaffe-to-present-at-the-ladenburg-thalmann-2021-healthcare-1293854)
- 2021-06-21 23:16 UTC [SEC Form 4] [SEC Form 4: Gray Robert bought $12,500 worth of Common Stock (2,000 units at $6.25), increasing direct ownership by 56% to 5,572 units](https://www.quantisnow.com/insight/sec-form-4-gray-robert-bought-12500-worth-of-common-1093274)
- 2021-05-26 21:13 UTC [SEC Form S-8] [SEC Form S-8 filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-hancock-jaffe-laboratories-inc-864149)
- 2021-05-25 21:15 UTC [SEC Form 4] [SEC Form 4: Glickman Marc H. bought $9,440 worth of Common Stock (1,600 units at $5.90)](https://www.quantisnow.com/insight/sec-form-4-glickman-marc-h-bought-9440-worth-of-846190)
- 2021-05-20 00:20 UTC [SEC Form 4] [SEC Form 4: BERMAN ROBERT ANDREW bought $16,410 worth of Common Stock (3,000 units at $5.47), increasing direct ownership by 408% to 3,736 units](https://www.quantisnow.com/insight/sec-form-4-berman-robert-andrew-bought-16410-worth-of-776749)
- 2021-05-20 00:18 UTC [SEC Form 4] [SEC Form 4: Duhay Francis bought $50,592 worth of Common Stock (9,492 units at $5.33), increasing direct ownership by 259% to 13,160 units](https://www.quantisnow.com/insight/sec-form-4-duhay-francis-bought-50592-worth-of-common-776725)
- 2021-05-12 18:22 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-hancock-jaffe-laboratories-inc-735153)
- 2021-05-10 11:00 UTC [CEO Presenting on the Emerging Growth Conference on May 12. Register here](https://www.quantisnow.com/insight/ceo-presenting-on-the-emerging-growth-conference-on-may-12-720021)
- 2021-05-07 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-hancock-jaffe-laboratories-inc-713921)
- 2021-04-30 13:15 UTC [SEC Form POS AM filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-hancock-jaffe-laboratories-inc-678800)
- 2021-04-23 16:40 UTC [Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One Year First-In-Human Data at Charing Cross International Symposium](https://www.quantisnow.com/insight/hancock-jaffe-principal-investigator-dr-jorge-hernando-ulloa-presents-venovalve-648454)
- 2021-04-07 17:40 UTC [First U.S. Patent Issues on Hancock Jaffe VenoValve](https://www.quantisnow.com/insight/first-us-patent-issues-on-hancock-jaffe-venovalve-596714)
- 2021-04-05 11:30 UTC [Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial](https://www.quantisnow.com/insight/hancock-jaffe-receives-ide-approval-to-begin-venovalve-us-pivotal-584161)
- 2021-03-31 21:15 UTC [SEC Form 10-K] [SEC Form 10-K filed by Hancock Jaffe Laboratories, Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-hancock-jaffe-laboratories-inc-574063)
- 2021-03-08 13:30 UTC [Hancock Jaffe Submits IDE Application to FDA for VenoValve U.S. Pivotal Trial](https://www.quantisnow.com/insight/hancock-jaffe-submits-ide-application-to-fda-for-venovalve-us-482566)
- 2021-02-24 22:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-429883)
- 2021-02-24 17:05 UTC [Public Offering] [First U.S. Patent Allowed on Hancock Jaffe VenoValve](https://www.quantisnow.com/insight/first-us-patent-allowed-on-hancock-jaffe-venovalve-428145)
- 2021-02-23 22:21 UTC [SEC Form 4] [SEC Form 4 filed by Craig Glynn](https://www.quantisnow.com/insight/sec-form-4-filed-by-craig-glynn-424849)
- 2021-02-23 22:18 UTC [SEC Form 3] [SEC Form 3 filed by Craig Glynn](https://www.quantisnow.com/insight/sec-form-3-filed-by-craig-glynn-424828)
- 2021-02-23 02:59 UTC [SEC Form 4] [SEC Form 4 filed by Francis Duhay](https://www.quantisnow.com/insight/sec-form-4-filed-by-francis-duhay-420743)
- 2021-02-23 02:58 UTC [SEC Form 4] [SEC Form 4 filed by Matthew Jenusaitis](https://www.quantisnow.com/insight/sec-form-4-filed-by-matthew-jenusaitis-420742)
- 2021-02-23 02:57 UTC [SEC Form 4] [SEC Form 4 filed by Sanjay Shrivastava](https://www.quantisnow.com/insight/sec-form-4-filed-by-sanjay-shrivastava-420741)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/HJLI
- Earnings history: https://www.quantisnow.com/earnings/HJLI
- Dividend history: https://www.quantisnow.com/dividends/HJLI
- Insider transactions: https://www.quantisnow.com/insiders/HJLI
- Options chain: https://www.quantisnow.com/options/HJLI
- SEC 8-K filings only: https://www.quantisnow.com/company/HJLI/8-k
- RSS and alerts for HJLI: https://www.quantisnow.com/docs/rss-feeds.md
